RESEARCH TRIANGLE PARK … Agricultural biotechnology is moving beyond its early commercial successes in improving crop production, as will be discussed at this month’s Biotechnology Roundtable, titled “Agricultural Biotechnology: Beyond the Farm Gate.”
The technology developed to achieve early successes, particularly in gene delivery and gene expression in plants, is today being applied to commercial objectives in agricultural product processing, enzyme production, industrial applications and pharmaceutical production. Coupled with the explosion of information from genomics and related technologies, agricultural biotechnology is making contributions in ways which challenge the label of agricultural biotechnology.”
The April 8 Roundtable will focus on some of the emerging applications of biotechnology using plants. Panelists from local companies who are leaders in this field will discuss the use of genetically engineered plants for both agricultural and pharmaceutical applications. They included Steve Evola, president of Syngenta Biotechnology; Mike Koziel, president and chief executive officer of Athenix Corporation and David Spencer, chief operating officer and vice president of research and development at Biolex.
Moderated by Gary M. Pace from the Hutchison & Mason law firm, the Biotechnology Roundtable is a collaborative program of the Council for Entrepreneurial Development and The North Carolina Biotechnology Center. It will be sponsored by
Elinvar & Technical Business Solutions.
The Roundtable will begin at 5:15 p.m. at the Biotechnology Center, 15 T.W.
Alexander Drive in RTP. The cost is $20 for CED members and $35 for non-members. For more information, contact Helena Lawrence at 919-549-7500, ext. 123, or hlawrence@cednc.org. Register online at
https://secure.hesketh.net/cednc/events/register/biotech_rndtbl.html
.